.svg){kind=small}
Where to Buy
Layup is stocked at 276 licensed dispensaries across New York and Connecticut, 271 of them in New York, with the deepest coverage in New York, Buffalo, Queens, Syracuse, and Albany. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Layup operated as a single-category brand with Beverage at 100.0% mix, posting 157.99% year-over-year growth and 8.61% month-over-month expansion, while average price fell 20.85% YoY to $4.64 and rose versus June by 8.61% on sales velocity. The combination of triple-digit YoY growth alongside a full-category concentration and a statewide rank of #2 in Beverage in New York indicates the brand is trading volume for scale under a narrower portfolio, and that current gains are tied more to depth within Beverage than to breadth across categories.
The price-volume tradeoff suggests Layup is leaning into accessible price tiers to accelerate unit throughput, with 157.99% YoY sales growth outpacing the 20.85% YoY price contraction and maintaining MoM momentum at 8.61% while holding the #2 rank in Beverage in New York. This pattern implies Layup’s positioning is anchored on penetration and repeat within Beverage rather than premiumization or category diversification, signaling headroom to defend or advance share by sustaining value-priced velocity before expanding beyond Beverage.
Competitive Landscape
Layup sits at #2 in NY Beverage in July 2026, unchanged from #2 year over year, with a flat 0-rank shift compared to April 2026 and a peak position matching #2 in July 2026; meanwhile, Ayrloom held #1 while its sales fell 5.36% year over year and Harney Brothers Cannabis advanced to #3 from #7 alongside a 327.37% year-over-year sales surge, indicating Layup’s steady #2 rank is being maintained against a softening leader and a rapidly advancing challenger, which implies the trajectory is stable but increasingly vulnerable to an overtake if momentum concentrates below the top spot.
Notable Products
Iced Tea Lemonade (10mg THC, 12oz, 355ml) posted the steepest decline in July 2026 at -60.34% and fell to rank 9, while Fruit Punch Lemonade (10mg THC, 12oz, 355ml) delivered the largest month-over-month gain at +56.35% and climbed to rank 4. Raspberry Tea (10mg THC, 12oz, 355ml) also surged +59.73% to rank 10, whereas Mango Tea (10mg THC, 12oz, 355ml) slipped -15.83% to rank 7. With eight of the top ten concentrated in Beverage lemonades and teas and Limeade Lemonade (10mg THC, 12oz, 355ml) holding rank 1 despite only +2.03% growth and $80,125 in sales, the pattern implies Layup is consolidating around flavor-led beverages while pruning weaker iced-tea variants.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
